Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated … B Dahlbäck, M Carlsson, PJ Svensson Proceedings of the National Academy of Sciences 90 (3), 1004-1008, 1993 | 2852 | 1993 |
Resistance to activated protein C as a basis for venous thrombosis PJ Svensson, B Dahlback New England Journal of Medicine 330 (8), 517-522, 1994 | 1618 | 1994 |
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA M Wieloch, A Själander, V Frykman, M Rosenqvist, N Eriksson, ... European heart journal 32 (18), 2282-2289, 2011 | 353 | 2011 |
The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis A Hillarp, B Zӧller, PJ Svensson, B Dahlbäck Thrombosis and Haemostasis 78 (09), 0990-0992, 1997 | 334 | 1997 |
Activated protein C resistance (FV: Q506) and pregnancy PG Lindqvist, PJ Svensson, K Maršál, L Grennert, M Luterkort, B Dahlbäck Thrombosis and haemostasis 81 (04), 532-537, 1999 | 331 | 1999 |
Cardiovascular risk factors associated with venous thromboembolism J Gregson, S Kaptoge, T Bolton, L Pennells, P Willeit, S Burgess, S Bell, ... JAMA cardiology 4 (2), 163-173, 2019 | 269 | 2019 |
Three-year survival and stroke recurrence rates in patients with primary intracerebral hemorrhage E Zia, G Engström, PJ Svensson, B Norrving, H Pessah-Rasmussen Stroke 40 (11), 3567-3573, 2009 | 252 | 2009 |
Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss–a possible evolutionary selection mechanism PG Lindqvist, PJ Svensson, B Dahlbäck, K Maršál Thrombosis and haemostasis 59 (01), 69-73, 1998 | 208 | 1998 |
Outcomes in a warfarin-treated population with atrial fibrillation F Björck, H Renlund, GYH Lip, P Wester, PJ Svensson, A Själander JAMA cardiology 1 (2), 172-180, 2016 | 183 | 2016 |
Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality N Isma, PJ Svensson, A Gottsäter, B Lindblad Thrombosis research 125 (6), e335-e338, 2010 | 161 | 2010 |